The U.S. Federal Trade Commission (FTC) has sent warning letters to 24 healthcare organizations, primarily large hospital systems, over concerns that their price disclosures are incomplete or potentially misleading.
Across the outlets, the regulator’s focus is on whether hospitals are meeting federal price transparency expectations and how gaps in pricing information could affect consumers. Fierce Healthcare reports the FTC tells hospitals that guidance from the Centers for Medicare and Medicaid Services (CMS) functions as a “regulatory floor,” implying that compliance should extend beyond basic adherence to CMS instructions. Healthcare Dive similarly describes the action as an escalation, linking the warnings to possible violations of federal consumer protection laws.
The sources also align that the FTC frames the letters within its broader authority under the FTC Act, including prohibitions on unfair or deceptive marketplace practices. While the letters are described as warnings, the articles do not indicate that penalties have been issued at this stage, instead emphasizing regulatory review and potential enforcement risk if pricing disclosures remain deficient or inaccurate.
